Medistem
San Diego
About Medistem
MediStem was founded in 2005 to develop, acquire and commercialize adult stem cell based therapeutic products. The company currently has 16 families of patent applications, Numerous scientific publications, and has out-licensed certain technologies to generate revenue. Medistem’s main candidate, the Endometrial Regenerative Cell is a universal donor pluripotent stem cell, currently being developed for an advanced form of peripheral artery disease called critical limb ischemia.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Funding stage: M&A
- Last round: Series A (Feb 2012)
- Website: medisteminc.com
- Phone: 858-352-7071
Industries & Categories
Biotechnology
Social Profiles
Canonical: https://fsome.com/organization/medistem-850240 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.